During the past decade, Queen Elizabeth II Medical Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Medical Centre" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Medical Centre" are "Contraception" (1 trials), "Erectile Dysfunction" (1 trials) and "Libido" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Medical Centre" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth II Medical Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "EV/DNG (Qlaira, BAY86-5027, SH T00658ID)" (1 trials), "Microgynon" (1 trials) and "Vardenafil ODT (STAXYN, BAY38-9456)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth II Medical Centre" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queen Elizabeth II Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Queen Elizabeth II Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth II Medical Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".